Journal Logo

Poster Session I: Indolent and mantle-cell non-Hodgkin lymphoma – Clinical

PF485 PARTIAL RESPONSE OR BETTER AT 6 MONTHS IS PROGNOSTIC OF PROGRESSION-FREE SURVIVAL IN PATIENTS WITH WALDENSTROM MACROGLOBULINEMIA TREATED WITH IBRUTINIB

Castillo, J.1; Abeykoon, J.2; Gustine, J.1; Zanwar, S.2; Keezer, A.1; Meid, K.1; Dubeau, T.1; Xu, L.1; Yang, G.1; Hunter, Z.1; Advani, R.3; Ansell, S.2; Gertz, M.2; Kapoor, P.2; Palomba, L.4; Treon, S.1

Author Information
doi: 10.1097/01.HS9.0000560240.75742.9f
  • Free

Abstract

Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.